Tender notice from Bulgaria, published on 22 Apr 2017.
Executive Summary
The D has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Bulgaria. This Tender notice was published on 22 Apr 2017 and is scheduled to close on 25 May 2017, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 12674435, while the tender notice number is 151984-2017 and Register on the platform.
Object of the contract Pharmaceutical products Description: Contract notice: Pharmaceutical products Authority Type: Body governed by public law Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union Award criteria: Lowest price CPV code: 33600000, 33600000, 33600000 CPV Description: Pharmaceutical products. "Delivery of medicinal products and medical foods for the needs of the hospital Dr. Stoicho Hristov EOOD, town of Sevlievo" The order includes 366 pcs. Medicines in 12 lots, described in the Technical Specification. NUTS Code: BG322 Main Site: Franco Warehouse Base of Dr. Stoicho Hristov Ltd Hospital, 147 Seven Peshev Street, Sevlievo, Hospital Pharmacy. OfferedThe item includes the following 48 nomenclatures and estimated quantities: 1.1. A02BA03 Famotidine tb. 20mg mg 900. 1.2. A02BA03 Famotidine powd.inj. 20mg solv. 5ml 3000. 1.3. A02BC01 Omeprazole powd.inj. 40 mg count 200. 1.4. A02BC05 Esomeprazole 40 mg powd. Inj. / Inf. 200. 1.5 A03AD01 Papaverine hydrochloride sol.inj. 20mg / ml 1ml 2000. 1.6. A03AD02 Drotaverine hydrochloride sol. Inj.20mg / ml - 2ml бр 3500. 1.7. A03BA01 Atropine sulfate sol.inj. 1mg/ml 1ml бр 500. 1.8. A03BB01 Hyoscine butylbromide sol. Inj. 20mg/ml 1ml бр 3000. 1.9. A03FA01 Metoclopramide hydrochloride sol.inj. 5mg/ml 2ml бр 2500. 1.10. A03DA02 Metamizole sodium 500mg/ml, Pitofenone hydrochloride 2mg/ml, Fenpiverine hydrochloride 0.02 mg/ml sol.inj. 2 ml бр 2000. 1.11. A03DA02 Metamizole sodium 500mg, Pitofenone hydrochloride 5mg, Fenpiverine hydrochloride 0.1mg тб 3000. 1.12. A05BA00 L-ornithin-L-aspartate conc.inf. 5g. 10ml бр 100. 1.13. A05BA03 Sylimarin capsuli. 90 mg caps 900. 1.14. A05BA03 Sylimarin caps. Hard 110 mg caps 900. 1.15. A06AA01 Liquid paraffin oral liq 40 g / течен парафин бр 50. 1.16. A06AB02 Bisacodyl supp. 10mg бр 240. 1.17. A06AD04 Magnesium sulfate powd.oral sol. 30 g бр 400. 1.18. A06AB05 Castor oil oral liquid 40 g бр 50. 1.19. A06AD65 Macrogol, Sodium sulfate anhydric, Sodium bicarbonate, Sod. Chloride, Potassium chlor. Powd. 64g бр 150. 1.20. A06AD65 Sodium chloride/ Potassium chlor./ Sodium hudrogen carbonate/ Macrogol 3350/Silika colloidal anhydrous -" powd.oral sol., 13, 8 g бр 200. 1.21. A07AA02 Nystatin 50000IU тб 100. 1.22. A07BA01 Medicinal sharcoat tb. 250 mg бр 100. 1.23.A07BC05 Diosmectite powd. 3g сашети 4000. 1.24. A07DA03 Loperamide hydrochloride 2 mg тб 4000. 1.25. A07EC02 Mezalazine tab.gastr.res. 250 mg тб 300. 1.26. A07EC02 Mezalazine tab.gastr.res. 500 mg тб 300. 1.27. A07FA02 Saccharomyces Boulardii sach. 250mg сашети 4000. 1.28. A09AA02 Pancreatine caps. gastr.res. тб 100. 1.29. A10AB01 Аctrapid sol inj 100 IU / ml / 3 ml бр 100. 1.30. A10AB05 Insulinaspart -" Novo Rapid -" 3 ml бр 10. 1.31. A10AE04 Insulin glargine -" Lantus Solostar -" 3 ml бр 5. 1.32. A10AE05 Insulin detemir -" Levemir Penfil 100 IU /ml -" 3 ml бр 10. 1.33. A10AB06 Insulin glulisine -" Apidra Solostar 100U/ml -" 3 ml бр 10. 1.34. A10AC01 Insulin /human/ -" Insulatard Penfil 3 ml. бр 30. 1.35. A10AD04 Insulin aspart -" Novo Mix Penfil -" 3 ml бр 20. 1.36. A10BB09 Gliclazide tb. modif.60mg тб 150. 1.37. A10BB12 Glimepirid 2 mg тб 60. 1.38. А11СС04 Calcitriol capsules, soft 0.25 mcg x 100 tb тб 1 000. 1.39. А11СС04 Calcitriol capsules, soft 0.25 mcg x 30 tb тб 6 000. 1.40. A11DB Thiamine nitrate, Pyridoxine hydrochl., Cyancobalamin film. coat tb.- 100 / 200/ 200 microgr тб 5000. 1.41. A11DB Thiamine hydr, Pyridoxine hydrochl., Cyancobalamin. Lidocaine hydr.- Sol inj -" 2 ml бр 5000. 1.42. A11GA01 Ascorbic acid 100 mg./ml. -" 5 ml., sol.inj. бр 2500. 1.43. A12AA03 Calcium gluconicum sol.inj. 8.94 mg/ml 10ml бр 1250. 1.44. A12CC05 Magnesium aspartat tetrahydrat 500 mg тб 300. 1.45. A12CC02 Magnesium sulphate 400 mg /10 ml бр 2000. 1.46. A12BA030 Magnesium DL -" aspartate 176 mg., Kalium DL -" aspartate hemuhydrant 166 mg тб 200. 1.47. A16AX01 Ademetionine., powd.inj. 500mg soLv, count 500. 1.48. A16AX01 Thioctic acid sol.inj. 600mg - 50ml count 250. 1. Participants in this procedure may be traders under the Bulgarian legislation or under the legislation of a Member State of the European Union or a State party to the Agreement on the European Economic Area who are authorized to carry out wholesale trade in medicinal products for which theWithin the meaning of Art. 195 and Art. 196 of the Law on Medicinal Products for Human Use (LMPHM): A) Natural and legal persons authorized to wholesale trade in medicinal products issued by a regulatory body of the respective Member State who have obtained a wholesale authorization for medicinal products from The Executive Director of the BDAProducer of medicinal products within the meaning of LMPHM, for medicinal products for which a manufacturing authorization has been issued. C) Importer of medicinal products within the meaning of LMPHM for medicinal products for which they have been granted an import authorization. Valid: - Authorization for wholesale of medicinal products; And / or - Certificate of RegistrarsFor wholesale trade on the territory of the Republic of Bulgaria to the persons authorized for this activity, issued by a regulatory body of the respective Member State; And / or - an authorization for the manufacture of medicinal products; And / or - Permission for import of medicinal products - For which medicinal products participate, issued by BDA - 2. When participating for nomenclatures 9.2; 9.3; 9.5; 9.16; 9.17; 9.18; 9.19; 9.35; 9.36; 9.38 of lot 9, which are drugs containing narcotic substances, the participants must be registered traders under the Bulgarian legislation or under the legislation of an EU Member State or a State party to the EEA Agreement which are entitled to trade Wholesale of medicinal products containing narcotic substances, according to Art. Listi?1/2II and III under Art. 3 (2) and (3) of the Ordinance on the Order for Classification of Plants and Substances as Narcotic Drugs, under the procedure of the Public Health Law. Participants must hold a license under Art. 32, para. (1) under the Narcotic Substances and Precursors Control Act. In order to prove the professional suitability, the participant provides (declares) in Part IV, letter "A" of EEDOP information about the circumstances under item 3.1.- number and date of issuance of a wholesale and / or certificate of wholesale registration in the territory of the Republic of Bulgaria to the persons authorized for this activity, issued by a regulatory body of the respective Member State and / or authorization For the manufacture and / or import of the medicinal products applied for under the LMPHM, respectively number and date of licenseUnder Art. 32, para. 1 under the Public Health Insurance Act - if applicable. 43 of the RAPPP in EEDOP shall provide data on the public registers, which contain information about the declared circumstances or the competent authority, which according to the legislation of the respective state is obliged to provide information of these circumstances of its own motion to the contracting authority. To demandBy the participant submitting the documents proving the information provided in EEDOP when it is necessary for the lawful conduct of the procedure ** At the stage of concluding a contract the participant selected for the contractor shall submit: - a certified copy of the License For wholesale and / or certificate of registration for wholesale trade on the territory of the Republic of Bulgaria to personsA, having a permit for this activity, issued by a regulatory body of Member State and / or authorization for the manufacture and / or import of medicinal products according to LMPHM - for nomenclature units: 9.2; 9.3; 9.5; 9.16; 9.17; 9.18; 9.19; 9.35; 9.36; 9.38 of lot No 9 - certified copy of license under Art. 32, para. 1 of the LCNMP. The Contracting Authority does not set up .-- Continued from field III.2.2): 4. Medicinal products derived from human blood or human plasma as well as medicinal products containing narcotic substances should be included in the Positive Drug List. The shelf life of the products at the time of delivery should be at least 60% of the declared by the manufacturer at the date of each delivery. Participant for nomenclature unit No 9.2 SevofluraNot inh. - 250 ml with vaporizers of the manufacturer must provide for the duration of the contract, for the duration of the contract, 3 vaporizers with a closed filling system with an adapter. Contractor calibration certificates and a workplace safety certificate must be submitted for the duration of the contract. The offered unit prices of the offered medicinal products do notAre moving the reference (maximum) values set in the current one at the date of initiation of the procedure Annex 2 to the Positive Drug List. A participant for whom there is any of the circumstances under Art. 54, para. 1 and Art. 55, para. 1, item 1 of the Public Procurement Act. The Contracting Authority shall withdraw from participation in the procedure and: - participants - related parties within the meaning of par. 2, item 45 of the PP of the Public Procurement Act; - a participant who is not entitled to participate in public procurement on the grounds of Art. 3, item 8 in the order with art. 5, para. 1, item 3 of the Economic and Financial Relations Act with the companies registered in jurisdictions with preferential tax regime, the persons controlled by them and their actual owners (ЗИФОДЮРСРЛТДС), except when the conditions under Art. 4 of the law; - a participant who has not submitted the justification under Art. 72, para 1 of the Public Procurement Act or whose offer has not been accepted according to Art. 72, para. (3) - (5) of the Public Procurement Act, - a participant who, on the invitation of the contracting authority and within the term specified therein, does not extend the period of validity of his tender, - a tenderer who has proposed a price for execution of the contract higher than the one specified by the contracting authority Estimated value of the order / unitPosition. As well as in case a unit price higher than the value indicated in column "Reference value of 1 pc. "- a participant who does not meet the selection criteria or a non-fulfillment of another condition specified in the contract notice or in the documentation;Who submitted a tender which does not comply with the pre-announced terms of the contract The participant declares the lack of grounds for removal and compliance with the selection criteria by submitting the EEDOP. On ax. Art. 47, para. 10 of the PPPP on the separate lots of the public procurement shall be allowed to submit 1 application for participation in the procedure III. Employer toShall place a bid on 1 or more of the lots. The participant may bid 1, several or all nomenclature units included in the respective lot. The Contracting Authority will require the designated contractor to provide a warranty guaranteeing the performance of the contract at the rate of 1 (one) per cent of its value, exclusive of VAT. The participant, designated as a contractor, chooses for himselfOf the performance guarantee - cash, bank guarantee or insurance. Payment terms - deferred, within 60 calendar days, after submission of the following documents: - invoice drawn up in compliance with the requirements of the VAT and RPSDDD - original and 1 / one / number of certified copy - receipt and transfer protocol. Pay the goods actually delivered during the term of the contract and notIs bound to the estimated quantities specified in the documentation Internet address (URL): http://mbal-sevlievo.com Directive: Classical Directive (2014/24/EU)
The bid deadline for Contract notice: Pharmaceutical products was 25 May 2017. Bidding is closed.
This tender has been issued by D in Bulgaria.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 12674435. The purchaser document reference is 151984-2017.